The acquisitions give StatLab, a developer and manufacturer of medical diagnostic supplies and equipment, a direct foothold in France, Germany, Italy and the United Kingdom.
SetPoint Medical secures $140 million to launch innovative neuroimmune modulation therapy for rheumatoid arthritis, advancing treatment for autoimmune diseases.